OK, folks, you have now convinced me and the science has convinced me even more so. I have used up much of my cash over the past two months, and that was built up over the past 6 months. In fact, I will now start to cash in some of my big pharma shares. The bargains abound, and I will start to average in, in some of the biotechs. Some of the biotechs have a better upside potential than that of PFE and PHA, my solid big pharma holdings. My first pick in this recent carnage, as of today, is and will continue to be CVTX. Thanks to several of my cyberbuds for helping me do my DD on this fine cardiovascular company with strong and competent leadership. I am now looking into the genomics companies, and aside from my current holdings in MLNM, am considering several others. Tops on my list are ABGX, MEDX and LEXG. I think these may still be weak in the short term, but selling at 2x cash? This is close to being unprecedented. As they say, the momentum pendulum has swung the opposite way and this represents a buying opportunity.
BJ |
